About Jennifer Lew
Jennifer Lew is a director at Boundless Bio.
Jennifer Lew reports to the SEC as a director or officer of 4 public companies, including Annexon (ANNX), Chinook Therapeutics (KDNY) and Dynavax Technologies (DVAX).
Jennifer Lew first appears on SEC filings in 2009.
Experience
This experience comes from SEC filings. The years are when the filings name Jennifer Lew in the role, so the role may have started earlier or lasted longer.
AI
Annexon, Inc.
EVP & Chief Financial Officer
2020 – 2026 · Public company (ANNX)
CI
Chinook Therapeutics, Inc.
Chief Financial Officer
2015 – 2019 · Public company (KDNY)
DC
Dynavax Technologies Corp.
VP, Finance & PAO
2009 – 2013 · Public company (DVAX)
Key Colleagues at Startups
The people Jennifer Lew works with at each company, as listed on that company's latest Form D.
Boundless Bio, Inc. · Form D, Aug 15, 2023
ZH
Zachary Hornby
CEO, President, and Director
BD
Benjamin Cravatt, Ph.D.
Director
FD
Fabio Pucci, Ph.D.
Director
JD
Jakob Loven, Ph.D.
Director
CD
Christine Brennan, Ph.D.
Director
JD
Jonathan Lim, M.D.
Director
KB
Kristina Burow
Director